News & Events

  • 13th Annual European Life Sciences CEO Forum

    When: Feb. 19th, 2020 to Feb. 20th, 2020
    Where: Zurich, Switzerland

    Anima Biotech has been invited to present an overview of its Translation Control Therapeutics Platform for the discovery of small molecule drugs that control mRNA translation during the 13th Annual European Life Sciences CEO Forum.

    The conference serves as a global biopharma industry forum that addresses the main challenges for 2020 investment, partnering and alliance management. Key players contribute their insights via panels, which cover the macro picture and innovation in different therapeutic sectors. The forum also features keynote speeches by KOLs and approximately 60 corporate presentations from established public and private emerging biotech companies.

    Download Press Release »

    Visit the conference website »

  • 2020 BIO CEO & Investor Conference

    When: Feb. 10th, 2020 to Feb. 11th, 2020
    Where: New York, USA

    Anima Biotech has been invited to present an overview of its Translation Control Therapeutics Platform for the discovery of small molecule drugs that control mRNA translation during the 2020 BIO CEO & Investor Conference.

    Now in its 22nd year, the BIO CEO & Investor Conference is one of the largest independent investor conferences focused on established and emerging publicly traded and select private companies. The conference prides itself on showcasing the best of biotech with two days of productive partnering meetings with institutional and early-stage investors, industry analysts and senior biotechnology executives.

    Download Press Release »

    Visit the conference website »

  • 6th Annual LSX World Congress

    When: Feb. 4th, 2020 to Feb. 5th, 2020
    Where: London, UK

    Anima Biotech has been invited to present an overview of its Translation Control Therapeutics Platform for the discovery of small molecule drugs that control mRNA translation during the 6thAnnual LSX World Congress. Yochi Slonim, Co-founder and Chief Executive Officer of Anima Biotech, will also participate with other experts as part of the “Platforms and Partnerships” panel.

    For five years, the LSX World Congress has been bringing together the executives that matter to the future of healthcare and life science business strategy, investment, partnering, deal-making, and commercialization. The LSX World Congress gathers the founders and CEOs of innovative start-ups through to publicly listed life science giants and everyone in between. It represents the breadth and depth of the cutting-edge research and technology driving the advances in the industry right now and in the near future.

     

    Download Press Release »

    Visit the conference website »

  • Biotech Showcase 2020

    When: Jan. 13th, 2020 to Jan. 15th, 2020
    Where: San Francisco, USA

    Anima Biotech has been invited to present an overview of its Translation Control Therapeutics Platform for the discovery of small molecule drugs that control mRNA translation during the Biotech ShowcaseTM 2020.

    Biotech Showcase™ is an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place. Investors and biopharmaceutical executives from around the world gather in San Francisco during this important week which sets the tone for the coming year. Now in its twelfth year, this rapidly growing conference features multiple tracks of presenting companies, plenary sessions, workshops, networking, and an opportunity to schedule one-to-one meetings.

    Download Press Release »

    Visit the conference website »

  • 2nd RNA- Targeted Drug Discovery Summit 2019

    When: Dec. 3rd, 2019 to Dec. 4th, 2019
    Where: Boston, USA

    Anima Biotech has been invited to present an overview of its Translation Control Therapeutics Platform for the discovery of small molecule drugs that control mRNA translation during the 2nd RNA- Targeted Drug Discovery Summit 2019. Yochi Slonim, Co-founder and Chief Executive Officer of Anima Biotech, will also participate with other experts as part of the “Targeting RNA with Small Molecules to Capture the Therapeutic Opportunities” panel.

    With numerous approaches emerging that demonstrate genuinely viable efficacy in targeting RNA, the 2nd RNA- Targeted Drug Discovery Summit is the only industry and translational focused conference dedicated to advancing pioneering RNA targeted small molecule therapeutics. For the 2nd year, at this event KOLs and RNA pioneers join to gain a comprehensive understanding on how to translate the first generation of RNA targeted small molecules into the clinic, delve into the exciting field of epitranscriptomics and stimulate discussion on how to successfully target RNA via RNA- modifying enzymes and interfering with RNA-protein interactions.

    Download Press Release »

    Visit the conference website »

  • Targeting RNA

    When: Nov. 26th, 2019 to Nov. 27th, 2019
    Where: Frankfurt, Germany

    Anima Biotech has been invited to present a talk on novel targets for small molecules between transcription and translation for lung fibrosis where they will discuss the discovery of lung-specific modulators of collagen translation and give insights into its Translation Control Therapeutics Platform for the discovery of small molecule drugs that control mRNA translation during the Targeting RNA Europe Congress 2019. Dr. Iris Alroy, Vice President of R&D of Anima Biotech, will also participate in a roundtable discussion on “Discussing RNA Functionality Issues such as Selectivity, Binding, Stability and Specificity” and in the “Treating the Unmet Need: Unleashing the RNA Space With Small Molecules” panel.

    The Targeting RNA Congress explores the ‘undruggable’ RNA space and showcases the latest advancements in modulation of RNA directly with small molecules and through epigenetics. The meeting brings together academic and industry leaders who are building platforms to identify and validate targets in order to assess disease relevance approaches in the RNA world.

    Visit the conference website »

  • BIO-Europe

    When: Nov. 11th, 2019 to Nov. 13th, 2019
    Where: Hamburg, Germany

    Anima Biotech has been invited to present an overview of its Translation Control Therapeutics Platform for the discovery of small molecule drugs that control mRNA translation during the 25th Annual BIO-Europe International Partnering Conference.

    BIO-Europe is Europe’s largest life science partnering conference offering countless opportunities to engage with global life science partners. This event features workshops and panels discussing the latest industry trends in biotech and pharma as well as company presentations and one-on-one partnering meetings.

    Download Press Release »

    Visit the conference website »

  • BIO Investor Forum

    When: Oct. 22nd, 2019 to Oct. 23rd, 2019
    Where: San Francisco, USA

    Anima Biotech has been invited to present an overview of its Translation Control Therapeutics Platform for the discovery of small molecule drugs that control mRNA translation during the 2019 BIO Investor Forum.

    The BIO Investor Forum is an international biotech investor conference focused on investment trends and opportunities in life sciences, with unbiased emphasis on venture-stage growth and emerging public companies as well as those poised to join the growth “watch list” in 2020. The event features plenary sessions, business roundtables and therapeutic workshops, company presentations, and BIO One-on-One Partnering™ meetings.

    Download Press Release »

    Visit the conference website »

  • BioJapan 2019

    When: Oct. 9th, 2019 to Oct. 11th, 2019
    Where: Yokohama, Japan

    Anima Biotech has been invited to present an overview of its Translation Control Therapeutics Platform for the discovery of small molecule drugs that control mRNA translation during the 2019 BioJapan World Business Forum. 

    BioJapan is Asia’s premier partnering event for the global biotechnology industry. BioJapan has been influential in furthering interaction between Japanese and global companies and advancing new business opportunities for nearly two decades. BioJapan draws in top business development, licensing, alliance management professionals, R&D personnel, and biotech company executives from around the world. 

    Download Press Release »

    Visit the conference website »

  • 19th Annual Biotech in Europe Forum Hosted by Sachs Associates

    When: Sep. 25th, 2019 to Sep. 26th, 2019
    Where: Basel, Switzerland

    Anima Biotech has been invited to present an overview of its Translation Control Therapeutics Platform for the discovery of small molecule drugs that control mRNA translation during the 19th Annual Biotech in Europe Forum hosted by Sachs Associates. Yochi Slonim, Co-founder and Chief Executive Offer of Anima Biotech, will also participate on a “Platform Technologies & Novel Therapeutics” panel.

    The Biotech in Europe Forum is the leading international stage for those interested in investing and partnering in the biotech industry. This event unites companies of all stages with leading investors, analysts, money managers and pharma licensing executives. Sachs estimates over 700 delegates and over 100 presenting companies, and 30+ pitches by seed companies.

    Download Press Release »

    Visit the conference website »

Pages